Karthik Radhakrishnan
Chief Financial Officer · Monopar Therapeutics
- 2024
- Oct 30, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Karthik Radhakrishnan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chandler Robinson - $2.56M in MNPR purchases and sales in the last 12 months
- Kim R. Tsuchimoto - $911K in MNPR purchases and sales in the last 12 months
- Raymond Anderson - $703K in MNPR purchases and sales in the last 12 months
- Christopher M. Starr - $659K in MNPR purchases and sales in the last 12 months
- Patrice Rioux - $111 in MNPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Karthik Radhakrishnan?
Karthik Radhakrishnan is a corporate insider, tracked as Chief Financial Officer of Monopar Therapeutics (MNPR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Karthik Radhakrishnan last file a Form 4?
The only primary Form 4 on record is dated 30 October 2024.
Has Karthik Radhakrishnan been buying or selling stock?
Recorded transactions: 1 open-market purchase ($25K) and 0 open-market sales across all tracked filings.
